The Novavax COVID-19 Vaccine, Adjuvanted is authorized for emergency use to provide a two-dose primary series to individuals 18 years of age and older. The primary series of two doses are given 3 weeks apart.

The Novavax COVID-19 Vaccine, Adjuvanted is authorized for emergency use to provide a two-dose primary series to individuals 18 years of age and older. The primary series of two doses are given 3 weeks apart.

This is the 1st shot Pfizer shot and is approved for 12 years and up.

This is the 2nd Pfizer shot approved for 12 years old and up.

A third dose of the primary vaccine series is approved for individuals who are immunocompromised.

This is 1st shot Moderna approved for 12 years old and up.

This is the 2nd Moderna shot approved for 12 years and up.

A third dose of the primary vaccine series is approved for individuals who are immunocompromised.

This Covid vaccine approved for 18 years old and up.